EMS SWISS DOLORCLAST

FDA Premarket Approval P050004

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approal for the ems swiss dolorclast. The ems swiss dolorclast is a non-surgical alternative indicated for the treatment of chronic proximal plantar fasciitis for patients 18 years of age or older with symptoms for 6 months or more and a history of unsuccessful conservative therapy. Chronic proximal plantar fasciitis is defined as heel pain in the area of the insertion of the plantar fascia on the medical calcaneal tuberosity.

DeviceEMS SWISS DOLORCLAST
Generic NameGenerator, Shock-wave, For Pain Relief
ApplicantELECTRO MEDICAL SYSTEMS (EMS SA)
Date Received2005-02-02
Decision Date2007-05-08
Notice Date2007-06-28
PMAP050004
SupplementS
Product CodeNBN 
Docket Number07M-0253
Advisory CommitteeGeneral & Plastic Surgery
Expedited ReviewNo
Combination Product No
Applicant Address ELECTRO MEDICAL SYSTEMS (EMS SA) ch. De La Vuarpilliere 31 nyon, Vaud CH-12-1260
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P050004Original Filing
S001 2009-02-25 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
07613353194895 P050004 000
07613353077464 P050004 001
07613353170264 P050004 001
07613353181284 P050004 001
07613353000011 P050004 001
07613353000028 P050004 001
07613353000035 P050004 001
07613353000042 P050004 001
07613353000059 P050004 001
07613353000066 P050004 001
04260153472031 P050004 001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.